Plan Snapshot
- Plan Sponsor: Apellis Pharmaceuticals, INC.
- Sponsor EIN: 271537290
- Sponsor Address: 100 5TH AVENUE, WALTHAM, MA, 02451
- Plan Type: 401(k)
- Total Participants: 615
- Total Assets: $88.0M
Key Plan Design Features
- Auto-Enrollment: Yes
- Auto-Escalation: No
- Allows Roth Contributions: No
- Participant Loans: Yes
- Participant-Directed Investments: Yes
- ERISA Section 404(c) Fiduciary Safe Harbor: Yes
Plan Financials by Year
| Year | Participants | Total Assets | Employer Contrib. | Employee Contrib. |
|---|---|---|---|---|
| 2024 | 615 | $88.0M | $5.1M | $11.5M |
| 2023 | 579 | $65.0M | $5.6M | $12.8M |
| 2022 | 694 | $40.9M | $4.5M | $9.4M |
Service Providers (Schedule C)
Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).
| Provider Name | Role | Direct Compensation | Indirect Compensation | Total Fees |
|---|---|---|---|---|
| GRAY GRAY AND GRAY, LLP | Auditor | — | — | $0 |
Plan Fees & Expenses
Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.
- Total Service Provider Fees: $0
Historical Administrative Expenses
Breakdown of administrative expense categories reported on Form 5500 filings.
| Year | Total Admin Expenses | Investment Mgmt Fees | Contract Admin Fees | IQPA Audit Fees | Professional Fees |
|---|---|---|---|---|---|
| 2024 | $3,166 | $7,825 | — | — | — |
| 2023 | $5,716 | $2,823 | — | — | — |
| 2022 | $6,087 | — | — | — | — |